1. Home
  2. GGT vs BDSX Comparison

GGT vs BDSX Comparison

Compare GGT & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gabelli Multi-Media Trust Inc. (The)

GGT

Gabelli Multi-Media Trust Inc. (The)

N/A

Current Price

$4.10

Market Cap

175.2M

Sector

Finance

ML Signal

N/A

Logo Biodesix Inc.

BDSX

Biodesix Inc.

N/A

Current Price

$55.08

Market Cap

153.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GGT
BDSX
Founded
1994
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Precision Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
175.2M
153.3M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
GGT
BDSX
Price
$4.10
$55.08
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$32.50
AVG Volume (30 Days)
309.8K
101.4K
Earning Date
01-01-0001
05-04-2026
Dividend Yield
15.56%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$88,499,000.00
Revenue This Year
N/A
$25.26
Revenue Next Year
N/A
$19.15
P/E Ratio
$5.08
N/A
Revenue Growth
N/A
24.08
52 Week Low
$3.87
$0.35
52 Week High
$4.39
$27.11

Technical Indicators

Market Signals
Indicator
GGT
BDSX
Relative Strength Index (RSI) 46.83 59.56
Support Level $4.09 $19.26
Resistance Level $4.27 N/A
Average True Range (ATR) 0.04 2.30
MACD -0.00 0.13
Stochastic Oscillator 18.75 80.44

Price Performance

Historical Comparison
GGT
BDSX

About GGT Gabelli Multi-Media Trust Inc. (The)

Gabelli Multimedia Trust Inc is a non-diversified closed-end management investment company. Its investment objective is the long-term growth of capital with income as a secondary objective. The fund invests majority of its assets, under normal market conditions, in common stock and other securities, including convertible securities, preferred stock, options, and warrants of companies in the telecommunications, media, publishing, and entertainment industries.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

Share on Social Networks: